Cas No.: 250612-42-1
PRODUCT INFORMATION
Description
Cyclo(RGDyK) is a powerful and selective inhibitor of the αVβ3 integrin. Its potency is well-documented, with a reported IC50 of 20 nM. This peptide is widely used in biomedical research as a tool to block integrin-mediated cell adhesion and signaling, and as a targeting moiety for conjugation to nanoparticles or imaging agents.
Molecular Weight
847.72
Purity
> 95%
Formula
C₃₁H₄₃F₆N₉O₁₂
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Tyr-Lys]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- CSTSMLKAC (disulfide) Targeting Peptide (CAT#: OLY-1025-YS-55)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- Cyclo(RGDyK) Targeting Peptide (CAT#: OLY-1025-YS-52)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.